A phase III clinical trial to study the tolerability and immunogenicity of V503, a multivalent human papillomavirus (HPV) L1 virus-like particle (BLP) vaccine, in 16- to 26-year-olds and 16- to 26-year-olds in women V5003-003-0069

Project: Research project

Project Details

Description

N/A
StatusFinished
Effective start/end date4/1/134/1/14